Global Next Generation Sequencing (NGS) Market

1
Global Next Generation Sequencing (NGS) Market
Industry Trends and Forecast to 2024
Global Next Generation Sequencing (NGS) Market,By
Product (Instruments (Hiseq series, Miseq series,
ION Torrent, SOLiD, Pacbio Rs II and Sequel
system), Consumables (Sample preparation
consumables, Other), Services (Sequencing
services, Data management services), by
Application (Diagnostics, Drug Discovery ,
Biomarker Discovery , Precision Medicine ,
Agriculture Animal Research), by End-user
(Hospitals Clinics, Research Centers and
Academic Government Institutes, and
Pharmaceutical Biotechnology Companies)
Browse Full Report and Details TOC
https//databridgemarketresearch.com/reports/glob
al-next-generation-sequencing-ngs-market
2
Report Description
Global Next Generation Sequencing (NGS) Market
accounted to USD 13.51 billion by 2022 growing at
a CAGR of 22.7 during the forecast period of
2017 to 2024. Next Generation Sequencing (NGS)
Market is also termed as high-throughput
sequencing. It is a DNA sequencing technology in
which millions and billions DNA strands are
sequenced. It has revolutionized genomic
research, as it minimizes the requirement for
fragment-cloning methods used in Sanger
sequencing of genomes.
3
Major Key Players

• Some of the major players operating in this
  market are
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Pacific Biosciences of California, Inc.
• QIAGEN
• BGI
• Oxford Nanopore Technologies
• PerkinElmer, Inc.
• GATC Biotech AG
• Agilent Technologies
• F. Hoffmann-La Roche Ltd
• Macrogen, Inc.
• Eurofins Scientific

Inquire Before Buying https//databridgemarketre
search.com/inquire-before-buying/?dbmrglobal-next
-generation-sequencing-ngs-market
4
Market Segmentation
By Technology the NGS market is segmented in
Sequencing by Synthesis, Ion Semiconductor
Sequencing, Sequencing by Ligation,
Pyrosequencing, Single Molecule Real Time
Sequencing. By Application the market is
classified in Diagnostics, Drug Discovery,
Biomarker Discovery, Precision Medicine,
Agriculture and Animal Research, Reproductive
Health, Personalized Medicine, Oncology, Clinical
Investigation, Forensics,. HLA typing/Immune
System Monitoring, Metagenomics,
Epidemiology. By End Users the market is spread
in Hospitals Healthcare institutions, Biotech
Pharma firms, Academic Government Research
Institutes, Pharmaceutical Companies,
Biotechnology Companies, Clinical Research.
Get Exclusive Sample Report _at_ https//databridgem
arketresearch.com/request-a-sample/?dbmrglobal-ne
xt-generation-sequencing-ngs-market
5
Regional Analysis

• Based on geography, the market is segmented into
  five geographical regions
• North America
• Europe
• Asia-Pacific
• South America
• Middle East
• Africa

6
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam Sopan.gedam_at_databridge
marketresearch.com